Fiche centre
Headache Science & Neurorehabilitation Center
Pavia — Italy
Essais liés2clinical trials
VillePavialocalisation
PaysItalylocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT06155123
Essais cliniques associés
2| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Monoclonal antibody targeting the CGRP pathway (ligand or receptor) (mAbs) | Migraine | À vérifier | NCT06155123 | HD-EEG Connectivity Changes in Migraine Patients Undergoing Treatment With Anti-CGRP mAbs | UNKNOWN |
| Atogepant 60 mg | Migraine | À vérifier | NCT06882122 | ATOM — Neurophysiological and Biomolecular Effects of Atogepant in Episodic Migraine | RECRUITING |